- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01733641
Test-Retest Reliability in DETECT
December 10, 2014 updated by: Tamara Espinoza, MD, Emory University
Test-Retest Psychometrics of a Novel Neuropsychological Assessment Tool: Reliability Measures for DETECT
Healthy volunteers without concussion, currently participating in non-or-limited contact sports teams at Emory University will undergo Display Enhanced Testing for Concussion and mild traumatic brain injury (mTBI) (DETECT) on three separate days: at baseline, day 50, and day 90.
Prior to enrollment participants will be allocated to the test-retest arm or the exercise arm.
Study Overview
Status
Terminated
Study Type
Observational
Enrollment (Actual)
44
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy volunteer athletes without concussion
Description
Inclusion Criteria:
- age > or = 16
- eligible for active participation during the National Collegiate Athletic Association (NCAA) season or member of the 2011 - 2012 or 2012-2013 club team
- Participation in a non or minimal contact sport
Exclusion Criteria:
- < age 16
- history of concussion in the previous 6 months
- any of the following: learning disabilities, attention deficient disorder, attention deficit hyperactivity disorder, depression or other psychiatric disorder, sleep apnea, seizure disorder, migraine headaches, previous central nervous system (CNS) surgery
- chronic drug or alcohol use; or drug or alcohol use with the previous 24 hours
- inability to complete the study protocol (90 days)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary Objective is to assess the reliability of the DETECT cognitive assessment tool, as measured by changes in DETECT scores from baseline in non-injured athletes.
Time Frame: 90 days
|
Subjects will complete the DETECT cognitive assessment tool at Baseline, 50 days, and 90 days.
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
April 1, 2013
Study Registration Dates
First Submitted
November 21, 2012
First Submitted That Met QC Criteria
November 21, 2012
First Posted (Estimate)
November 27, 2012
Study Record Updates
Last Update Posted (Estimate)
December 12, 2014
Last Update Submitted That Met QC Criteria
December 10, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- IRB00052187
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reliability Properties of a Concussion Screening Tool
-
Alison GalbraithNational Institute on Aging (NIA); Massachusetts Institute of Technology; Harvard... and other collaboratorsCompletedno Specific Condition Targeted | Use of a Price Transparency ToolUnited States
-
University Hospital, AngersCompletedto Elaborate a New Simple Clinical Tool for the Risk of Falls Among Older Inpatients.France
-
European Foundation for the Care of Newborn InfantsNot yet recruitingSelf-Assessment | Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health | Testing of the Developed Self-assessment Tool in European HospitalsGermany
-
Herlev HospitalCompletedFocus of Study: Usability of a Tool for Structured Assessment of and Feedback to Trainee SurgeonsDenmark
-
University of PennsylvaniaCompletedIn Need of a Pap Smear (Cervical Cancer Screening) | In Need of a Blood Pressure Check (Hypertension Screening) | In Need of a Cholesterol Test (Lipid Disorder Screening) | In Need of a Fasting Plasma Glucose Test (Diabetes)United States
-
Radboud University Medical CenterCompletedLow Back Pain | Type of Leg Pain (Radicular, Non-radicular) | Lifestyle (Sedentary Behavior and Physical Activity) | Start Back Screening ToolNetherlands
-
Nantes University HospitalTerminatedCirrhotic Patient With Suspicion of Portal Hypertension and in a OV Screening ContextFrance
-
Centre hospitalier de l'Université de Montréal...Fonds de la Recherche en Santé du QuébecTerminatedActive or Ex-injection Drug Users | Indication of Hepatitis C ScreeningCanada